editor.ajphr@gmail.com
9409046853
e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

📢 Latest Update: Call for Papers for a Peer Reviewed Open Access Pharmacy Journal with Fast Publication

📢 Latest Update: Call for Papers for a Peer Reviewed Open Access Pharmacy Journal with Fast Publication

Volume 9, Issue 4 - 2021 (April 2021 Issue 4)

Volume 9 Issue 4 Cover

Issue Details:

Volume 9 Issue 4
Published:Apr 2, 2026

Editorial: April 2021 Issue 4

Welcome to the 2021 issue of American Journal of Pharmacy and Health Research. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr H J Patel
Editor-in-Chief
American Journal of Pharmacy and Health Research

Articles in This Issue

Showing 1 of 1 articles
Research PaperID: AJPHR904001

Post – Stroke Depression: A Review

Silvia Navis, Bincy Ravi, Shahin S, Prasobh GR

ABSTRACTThe third leading cause of death is stroke, mainly occurred in patients with 50 years or more and it is described as a sudden loss of blood flow to the brain that leads to irreversible tissue damage caused by thrombotic, embolic, or hemorrhagic events. While stroke related psychiatric complications have been recognized for over a century, they have never received the same degree of attention as post stroke motor deficits, language difficulties, or intellectual disturbances. Some of these stroke clinical complications, such as depression and whereas anxiety or emotional liability are other complications. Depression after stroke is associated with a lower quality of life and also with a higher risk of dying. After a stroke, approximately one third of patients experience depression. It’s important to correctly test for and diagnosis post stroke depression, as well as determine the seriousness of the disease. PSD is related to a variety of stroke risk factors and it can be fatal if left untreated. There is good evidence that early initiation of antidepressant treatment is associated with a decreased risk of developing and successful prevention of PSD in non depressed stroke patients. PSD requires special care, and consensus on the diagnosis and treatment of PSD should be achieved. Keywords: Antidepressant, depression, Post stroke depression, Stroke

AntidepressantdepressionPost stroke depressionStroke
100,529 views
30,168 downloads

Contributors:

 Silvia Navis
,
 Bincy Ravi
,
 Shahin S
,
 Prasobh GR
Whatsapp